REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 48 filers reported holding REDHILL BIOPHARMA LTD in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $73,000 | -13.1% | 12,000 | 0.0% | 0.01% | -16.7% |
Q3 2019 | $84,000 | +7.7% | 12,000 | 0.0% | 0.01% | +9.1% |
Q2 2019 | $78,000 | -22.0% | 12,000 | 0.0% | 0.01% | -21.4% |
Q1 2019 | $100,000 | +49.3% | 12,000 | 0.0% | 0.01% | +27.3% |
Q4 2018 | $67,000 | -36.8% | 12,000 | 0.0% | 0.01% | -21.4% |
Q3 2018 | $106,000 | -38.0% | 12,000 | -40.0% | 0.01% | -41.7% |
Q2 2018 | $171,000 | +66.0% | 20,000 | 0.0% | 0.02% | +71.4% |
Q1 2018 | $103,000 | +102.0% | 20,000 | +100.0% | 0.01% | +133.3% |
Q4 2017 | $51,000 | – | 10,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 717,203 | $9,962,000 | 0.89% |
BANK HAPOALIM BM | 147,504 | $2,049,000 | 0.48% |
MENORA MIVTACHIM HOLDINGS LTD. | 246,000 | $3,417,000 | 0.19% |
Family Management Corp | 16,500 | $229,000 | 0.13% |
Orbimed Advisors | 564,900 | $7,846,000 | 0.09% |
SABBY MANAGEMENT, LLC | 63,800 | $888,000 | 0.03% |
INGALLS & SNYDER LLC | 41,550 | $577,000 | 0.03% |
Candriam S.C.A. | 71,267 | $992,000 | 0.02% |
MONETARY MANAGEMENT GROUP INC | 3,000 | $42,000 | 0.02% |
D.A. DAVIDSON & CO. | 26,500 | $368,000 | 0.01% |